LONDON, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and 100 ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...
Novo Nordisk (NVO) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...
Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' ...
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
THE CHOSUNILBO on MSN7d
Novo Nordisk’s phase 3 Alzheimer’s trial advances in S. KoreaNovo Nordisk is conducting a large-scale clinical trial for Alzheimer’s disease, an area of research fraught with challenges.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback